Mastercard Inc. (0R2Z)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 615.74 |
|---|---|
| 52-week range | 357.20 – 625.87 |
| Return, 1 month / 3 months | +8.4% / +13.6% |
| Return, 1 year / 3 years | +9.6% / +74.4% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 73.8% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 2.40M USD |
| Dividend yield | 0.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mastercard runs a global payments network that connects cardholders, merchants and financial institutions. It issues payment cards under its brand through banks and other issuers, authorises and settles card transactions, and provides related services such as fraud detection, data analytics and consulting. Its customers are banks, merchants, businesses and governments around the world. The company is based in Purchase, New York, in the United States.
On this site Mastercard Inc. appears as a stock on the London Exchange (UK), code 0R2Z, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mastercard Inc. (0R2Z) trades on the London Exchange in UK. It last closed at USD 615.74 on 19 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,609 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.6% and over the last three months it rose 13.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 15.9% | ||
| From 52-week high | -0.3% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.6% | ||
| 6-month return | 18.5% | ||
| 12-month return, skipping the last month | 1.2% | ||
| Stability (higher is calmer) | 22 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 73.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 61 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.40M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | +8.4% |
| 3 months | +13.6% |
| 6 months | +18.5% |
| 1 year | +9.6% |
| 3 years | +74.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 570.21 / 531.07 |
|---|---|
| Golden / death cross (60 days) | Golden, 43 days ago |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 19.85 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 Oct 2026 | USD 0.8700 |
| 8 Jul 2026 | USD 0.8700 |
| 8 Apr 2026 | USD 0.8700 |
| 8 Jan 2026 | USD 0.8700 |
| 8 Oct 2025 | USD 0.7600 |
| 8 Jul 2025 | USD 0.7600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.